medigraphic.com
ISSN 0188-2198 (Print)

2011, Number 2

Next >>

Rev Mex Cardiol 2011; 22 (2)

Comparison of antropometric indicators as predictors of cardiovascular and metabolic risk in health population

González CA, Ureña LJ, Lavielle SMPD, Amancio CO, Elizondo AS, Hernández HH

Language: Spanish
References: 33
Page: 59-67
PDF size: 350.54 Kb.


ABSTRACT

There is a continuing discussion on the assessment methods of obesity, abdominal obesity can be evaluated with different somatometric indices and be seen as a better indicator of risk for developing metabolic disorders and cardiovascular disease. Material and methods: Cross-sectional descriptive study in Mexican population over 18 apparently healthy, anthropometric measurement was performed by determining body mass index (BMI), waist-hip ratio (WHR), waist-height (ICT) and waist circumference (PC). Risk factors were blood pressure, fasting and postload glucose, triglycerides, HDL (high density lipoprotein), insulin and uric acid. The relationship between anthropometric indicators and risk factors was analized by χ2 and comparison of indicators by logistic regression test. Results: 188 participants, 65 men and 123 women, men showed a greater number of factors associated with abdominal obesity. BMI in the multivariate analysis showed better association with other indicators, and was more significant for hypertriglyceridemia [OR 1.03; 95% CI (1.01-8.1)] and for the presence of 3 or more metabolic risk factors [OR 2.67, 95% IC (1.0-7.023)]. In the case of abdominal obesity markers showed association between ICC and altered HDL [OR 3.0, 95% CI (1.41-6.53)]. Discussion: There is consistent association between cardiovascular risk factors and all indicators of abdominal obesity, somatometric indices matter what turns out to be a better predictor, and the findings suggest that there is no superiority between using indicators for abdominal obesity or general adiposity.


REFERENCES

  1. Pérez NE, Morales EML, Grajales AI. Panorama epidemiológico de la obesidad en México. Rev Mex Enf Cardiol 2006; 14: 62-64.

  2. Ono T, Guthold R, Strong K. WHO global Comparable Estimates. WHO, 2005.

  3. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T y cols. Encuesta Nacional de Salud y Nutrición 2006.

  4. Richard NB, Kim S, Hsu I et al. Abdominal obesity: Role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 2007; 120: S3-S8.

  5. Kaess BM, Jozwiak J, Mastej M. Association between anthropometric obesity measures and coronary artery disease: a cross sectional survey of 16 657 subjects from 444 Polish cities. Heart 2010; 96: 131-135.

  6. Gruson E, Montaye M, Kee F et al. Obesity and coronary heart disease risk in men: the PRIME study. Heart 2010; 96: 136-140.

  7. Tabata S, Yoshimitsu S, Hamachi T et al. Waist circumference and insulin resistance: a cross-sectional study of Japanese men. BMC Endocrine Disorders 2009; 9: 1.

  8. Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 2007; 120: 10-17.

  9. Bosy-Westphal A, Geisler C, Onur S et al. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes 2006; 30: 475-83.

  10. Lee K, Song YM, Sung J. Which obesity indicators are better predictors of metabolic risk?: healthy twin study. Obesity 2008; 16: 834-840.

  11. Westphal SA. Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone. 2008; 9: 23-29.

  12. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nut 2004; 79: 379-84.

  13. Qiao Q, Nyamdorj. Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index? Eur J Clin Nutr 2010; 64: 30-4.

  14. Carroll JF, Chiapa AL, Rodriguez M et al. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity 2008; 16: 600-7.

  15. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002; 3: 141-6.

  16. Santi MJ, Carrozas MA, Barba A et al. Waist circumference as a predictor of insulin resistance in young men. Med Clin 2005; 125: 46-50.

  17. Oliveira MA, Fagundes RL, Moreira EA et al. Relation between anthropometric indicators and risk factors for cardiovascular disease. Arq Bras Cardiol 2010; 94: 478-85.

  18. Łopatyński J, Mardarowicz G, Szcześniak G. A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus. Ann Univ Mariae Curie Sklodowska Med 2003; 58: 413-9.

  19. Sayeed MA, Mahtab H, Latif ZA et al. Waist-to-height ratio is a better obesity index than body mass index and waist-to-hip ratio for predicting diabetes, hypertension and lipidemia. Bangladesh Med Res Counc Bull 2003; 29: 1-10.

  20. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans-a 7-year prospective study. Obes Res 1997; 5: 16-23.

  21. Hadaegh F, Zabetian A, Harati H et al. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men: a 3.6-year prospective study. Exp Clin Endocrinol Diabetes 2006; 114: 310-5.

  22. Bergman RN, Kim SP, Hsu IR et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. The American Journal of Medicine 2007; 120: S3-S8.

  23. Bray GA, Jablonski KA, Fujimoto W et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nut 2008; 87: 1212-8.

  24. González-Chávez A, Amancio-Chassin O, Islas-Andrade S et al. Cardiovascular risk factors associated to abdominal obesity in apparently healthy subjects. Rev Med Inst Mex Seguro Soc. 2008; 46: 273-9.

  25. Berber A, Gómez-Santos R, Fanghänel G et al. Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population. Int J Obes Relat Metab Disord 2001; 25, 12: 1794-9.

  26. Sánchez-Castillo CP, Velásquez-Monroy O, Berber A et al. Anthropometric cutoff points for predicting chronic disease in the Mexican National Health Survey 2000. Obes Res 2003; 11: 442-451.

  27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28(1): s37-s42.

  28. Kawada T, Otsuka T, Inagaki H et al. Insulin resistance, as expressed by HOMA-R, is strongly determined by waist circumference or body mass index among Japanese working men. Obesity Research & Clinical Practice 2010; 4: e9-e14.

  29. Guh DP, Zhang W, Bansback N et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 25;9: 88.

  30. González-Chávez A, Simental L, Elizondo-Argueta S y cols. Prevalencia del síndrome metabólico entre adultos mexicanos no diabéticos, usando las definiciones de la OMS, NCEP-ATPIIIa e IDF. Rev Med Hosp Gen Mex 2008; 71: 11-19.

  31. Chiarello F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol 2008; 159: S67-S74.

  32. Nolan JJ, Ludvik B, Baloga J, Reuchart D, Olefsky JM. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM. Diabetes 1997; 46: 494-500.

  33. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesityrelated health risk factors. JAMA 2003; 289: 76-9.




2020     |     www.medigraphic.com